Biosynth Life Sciences India Limited

Biosynth Life Sciences India Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials and compliance.
CIN U24234TN2006PLC059506 Incorporated 13 April 2006 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2023
-
▼ 100.00% YoY
EBITDA · FY 2023
*****
▼ 1404.11% YoY
Net profit · FY 2023
*****
▼ 110.34% YoY
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
20 yrs
Est. 2006
Last financials
Mar 2024
Balance sheet date

About Biosynth Life Sciences India Limited

Data last updated: 20 December 2025

Biosynth Life Sciences India Limited is a public limited company based in Chennai, Tamil Nadu, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 13 April 2006, the company has been in operation for over 20 years.

Registered with ROC Chennai under CIN U24234TN2006PLC059506.

Capital: an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Srinivasan Ranganathan and Ganesan Anandanarayanan.

Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Dhun Building No.827 Anna Salai, Chennai, Tamil Nadu, India – 600002.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biosynth.co.in.

Company Details of Biosynth Life Sciences India Limited
CIN U24234TN2006PLC059506
Registration Number 059506
Incorporation Date 13 April 2006
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Key People
Srinivasan Ranganathan Director Ganesan Anandanarayanan Director Venkateswaran Natarajan Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    biosynth.co.in
  • Social Media
    **************
  • Registered Address
    Dhun Building No.827 Anna Salai, Chennai, Tamil Nadu, India – 600002
  • Industry
    Pharma, Drug Formulation & Development
Company report
Biosynth Life Sciences India Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Biosynth Life Sciences India Limited report

Financials, compliance, directors, charges, ownership and filings for Biosynth Life Sciences India Limited in one report.

10-year financials Directors & ownership Charges & compliance

Auditor Details of Biosynth Life Sciences India Limited

Biosynth Life Sciences India Limited is audited by P.S.SUBRAMANIA IYER & CO for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
P.S.SUBRAMANIA IYER & CO blur-value blur-value blur-value

Board of Directors of Biosynth Life Sciences India Limited

Biosynth Life Sciences India Limited is currently managed by 3 directors, with 10 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Srinivasan Ranganathan
Also directs: Coromandel Travels Limited, Chennai Super Kings Cricket Limited, Superking Ventures Private Limited
Director 23 Jan 2012 14 Years 5 Months Current
Ganesan Anandanarayanan
Also directs: Coromandel Packaging Private Limited, Jhunjhunu Cement Limited, Sri Saradha Logistics Private Limited and 3 more
Director 15 Feb 2024 2 Years 4 Months Current
Venkateswaran Natarajan
Also directs: Coromandel Packaging Private Limited, Raasi Cement Limited, Jhunjhunu Cement Limited
Director 06 Feb 2014 12 Years 5 Months Current
View all directors

Financials of Biosynth Life Sciences India Limited FY 2024 filings available

Biosynth Life Sciences India Limited reported revenue of ₹- (down -100.00% YoY) for FY 2023. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
- ▼ -100.00%
Profit
***** ▼ -110.34%
EBITDA
***** ▼ -1404.11%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Shareholding Pattern of Biosynth Life Sciences India Limited

As of FY 2023, Biosynth Life Sciences India Limited's shareholding pattern shows 15.00% by promoters, 85.00% by public shareholders. Public shareholders hold the majority stake, reflecting broad public ownership.

2025
YEAR
38.19% Promoters
25.22% DII (Domestic Institutional)
10.28% FII (Foreign Institutional)
25.89% Public
2.42% Others
Shareholding Trend
Year 2025
Promoters 33.19%
DII 23.22%
FII 18.28%
Public 22.89%
Others 2.42%

Charges & Borrowings Biosynth Life Sciences India Limited

Biosynth Life Sciences India Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Biosynth Life Sciences India Limited

View historical data on people associated with Biosynth Life Sciences India Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Biosynth Life Sciences India Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Biosynth Life Sciences India Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Biosynth Life Sciences India Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Biosynth Life Sciences India Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Biosynth Life Sciences India Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Biosynth Life Sciences India Limited

MSME Payment Delays by Biosynth Life Sciences India Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Biosynth Life Sciences India Limited

Subsidiaries & Group Companies of Biosynth Life Sciences India Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Biosynth Life Sciences India Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Biosynth Life Sciences India Limited

MCA Filings & Documents of Biosynth Life Sciences India Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Biosynth Life Sciences India Limited

Activity
30 Sep 2024
Biosynth Life Sciences India Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Activity
31 Mar 2024
Biosynth Life Sciences India Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Directors
15 Feb 2024
Ganesan Anandanarayanan was appointed as a Director on 15 Feb 2024 & has been associated with this company since 2 years 4 months.
Directors
06 Feb 2014
Venkateswaran Natarajan was appointed as a Director on 06 Feb 2014 & has been associated with this company since 12 years 5 months.
Directors
23 Jan 2012
Srinivasan Ranganathan was appointed as a Director on 23 Jan 2012 & has been associated with this company since 14 years 5 months.
Activity
13 Apr 2006
Biosynth Life Sciences India Limited was registered on 13 Apr 2006 with Roc Chennai & aged 20 years 2 months as per MCA records.

Frequently Asked Questions about Biosynth Life Sciences India Limited

Biosynth Life Sciences India Limited is an active public limited company in the pharma sector based in Chennai, Tamil Nadu, India. It was incorporated on 13 April 2006 (20+ years old) and is registered under CIN U24234TN2006PLC059506.

The current directors of Biosynth Life Sciences India Limited are:

The primary industry of Biosynth Life Sciences India Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Biosynth Life Sciences India Limited can be reached at the registered office: Dhun Building No.827 Anna Salai, Chennai, Tamil Nadu, India – 600002, or through the website biosynth.co.in.

The authorised capital is ₹10 Lakh, and the paid-up capital is ₹5 Lakh.

The company has its registered office at Dhun Building No.827 Anna Salai, Chennai, Tamil Nadu, India – 600002.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available